Coherus Oncology, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CHRS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -25.83 M-46.63 M-46.34 M-19.72 M-57.89 M -170.57 M Cash from investing activities -17.49 M462.64 M-67.23 M-2.84 M30.66 M 423.23 M Cash from financing activities -264 K-281.52 M2 0008.08 M53.59 M -219.85 M Free cash flow -25.83 M-46.63 M-46.34 M-19.72 M-57.89 M -170.57 M

News

Coherus Oncology: Setting Up For Important Readouts In Mid-2026 (NASDAQ:CHRS)

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift

Oppenheimer reiterates Coherus Biosciences stock rating at Outperform

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus BioSciences earnings matched, revenue fell short of estimates

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates